COVID-19 Vaccine Booster Clinic for Scheduled Appointments Opens at Rutland Regional
Rutland Regional Medical Center has partnered with the Vermont Department of Health (VDH) to open a COVID-19 vaccine site for booster shots. To receive a booster, residents must make an appointment through the VDH website: https://www.healthvermont.gov/myvaccine
“We are happy to work with the Vermont Department of Health (VDH) to increase the availability and convenience of the COVID-19 vaccine to our community,” said Jonathan Reynolds, Vice President of Clinic Services at Rutland Regional. “It is vitally important that we continue to do what we can to protect ourselves and others from the COVID-19 virus.”
The COVID-19 booster clinic will take place in the upper level of the newly built Thomas W. Huebner Medical Office Building on the hospital campus. Access to the clinic will be from the upper parking lot on Allen Street near the Specimen Collection Center.
“The booster is only one shot and does not require staffing at the level of the initial round of vaccines,” said Leah Denton, Senior Director of Clinical Services. “We are able to roll the boosters out as people become eligible either by the fact that they are six months from their last dose, or they meet certain criteria.”
The COVID-19 Booster Vaccination Clinic will take place at Rutland Regional’s Thomas W. Huebner Medical Office Building Wednesdays through Saturdays, from 7:30am to 6pm. There will be a slight change to the clinic hours and days during Thanksgiving week, which will be noted as part of the booster sign-up through the VDH website. VDH will also be using the COVID-19 Vaccine Clinic at Rutland Regional to schedule the initial COVID-19 vaccine.
“We did such a great job as a community in getting people fully vaccinated,” Denton continued. “We are committed to continuing to protect our neighbors and friends for as long as it takes during this pandemic.”
In September, the Centers for Disease Control announced that the efficacy of the Pfizer COVID-19 vaccine lessens over time. They recommended and approved a Pfizer COIVD-19 booster vaccine for eligible individuals who were more than six months and beyond from their last (second) dose and 65 years or older, or 18 years or older and working in high-risk occupational and institutional settings, live in a long-term care facility, or have underlying medical conditions.